A new USC-led study suggests that assessing blood vessel health should be included in dementia diagnostics. A new USC-led ...

Think your brain is too old to learn new tricks, let alone keep cognitive decline at bay? Think again. Research featured in the journal Cell Stem Cell in 2019 revealed that neurons continue to form in ...

The following is a summary of “Microenhancement as a Biomarker for Cerebral Microbleed in Inflammatory Cerebral Amyloid ...

Older people who regularly drink green tea have fewer brain lesions are characteristic of dementia than those who do not ...

Blarcamesine potential novel oral treatment to target upstream Alzheimer’s disease pathology through autophagy enhancementImpairment of autophagy ...

Expanded clinical practice guidelines aim to empower all clinicians, regardless of specialty or practice setting to evaluate ...

( MENAFN - JCN NewsWire) FDA Accepts LEQEMBI (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the treatment of Early Alzheimer's disease LEQEMBI is the only ...

If approved, subcutaneous autoinjector Leqembi will be the only Alzheimer's medication that can be administered at home. The ...

Mild cognitive impairment is linked to blood vessel dysfunction in the brain's temporal lobes—the seat of memory—according to a new USC-led study.

The study suggests that mild cognitive impairment is linked to blood vessel dysfunction in the brain’s temporal lobes. The ...

Mild cognitive impairment is linked to blood vessel dysfunction in the brain's temporal lobes - the seat of memory - according to a new USC-led study.